San Diego, CA, United States of America

John S Tyhonas

USPTO Granted Patents = 15 

Average Co-Inventor Count = 7.5

ph-index = 5

Forward Citations = 80(Granted Patents)


Location History:

  • Chula Vista, CA (US) (2012)
  • San Diego, CA (US) (2002 - 2023)

Company Filing History:


Years Active: 2002-2023

Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Contributions of John S. Tyhonas

Introduction

John S. Tyhonas is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 15 patents, he has made strides in developing innovative treatments for various diseases.

Latest Patents

Among his latest patents are the "Inhibitors of Raf Kinases," which provide pharmaceutical compositions comprising compounds that inhibit receptor tyrosine kinase effector, RAF. These compounds are designed for the treatment of diseases. Another notable patent is the "Inhibitors of MET Kinase," which includes pharmaceutical compositions that utilize MET receptor tyrosine kinase inhibitory compounds for disease treatment.

Career Highlights

Throughout his career, John has worked with Kinnate Biopharma Inc., where he has played a crucial role in advancing therapeutic solutions. His expertise in kinase inhibitors has positioned him as a key figure in the pharmaceutical industry.

Collaborations

John has collaborated with notable professionals in his field, including Toufike Kanouni and Stephen W. Kaldor. Their combined efforts have contributed to the development of innovative treatments and advancements in pharmaceutical research.

Conclusion

John S. Tyhonas exemplifies the spirit of innovation in the pharmaceutical industry through his extensive patent portfolio and collaborative efforts. His work continues to impact the treatment of diseases, showcasing the importance of inventors in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…